NEW YORK, Aug. 4, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
Microneedle Drug Delivery: Technology, Devices, Markets, Players
and Prospects
http://www.reportlinker.com/p0581179/Microneedle-Drug-Delivery-Technology-Devices-Markets-Players-and-Prospects.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
Microneedle technology is an enabling technology base for the
development of needles with micro scale cross sectional dimensions
and added functionality. The microneedles can be used for
conventional drug delivery and sample extraction applications as
well as for integration with other miniaturized biochemical
analysis systems. The needles are enabling for the manipulation of
micro volumes of samples as well as for parallel distribution of
samples or reagents on a close center-to-center spacing. The
commercialization of microneedle drug delivery devices such as the
sanofi-aventis Intanza influenza vaccine, which is based on the
Becton Dickinson Soluvia syringe-mounted microneedle array device,
is a milestone in the transition of microneedle drug delivery from
development to market place. Microneedle technology promises to
impact health care by allowing the precise injection of therapeutic
agents to prescribed locations below the skin.
Highlights
• Analyzes and evaluates microneedle technology and product
research and development, and assesses the medical market potential
for existing and probable future products
• Analyzes proprietary technologies and market
develop
‘/>”/>
SOURCE